Hereditary breast cancer beyond BRCA: Clinical and histopathological characteristics in patients with germline CHEK2, ATM, PALB2 and TP53-mutations

被引：1
|
作者：
Hoste, G. [1 ]
D'Hoore, P. [1 ]
Legius, E. [1 ]
Van Buggenhout, G. [1 ]
Floris, G. [1 ]
Wildiers, H. [1 ]
Han, S. N. [1 ]
Van Nieuwenhuysen, E. [1 ]
Berteloot, P. [1 ]
Smeets, A. [1 ]
Nevelsteen, I. [1 ]
Weltens, C. [1 ]
Janssen, H. [1 ]
Van Limbergen, E. [1 ]
Neven, P. [1 ]
Punie, K. [1 ]
机构：
[1] Univ Hosp Leuven, Leuven, Belgium
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P5-09-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-09-05
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Real-world clinical characteristics and management of breast cancer in patients with germline pathogenic variants in ATM, CHEK2 and PALB2
    Brzeskiewicz, Laura
    Roscow, Breanna
    Beeks, April
    Kunz, Barb
    Ratzel, Sarah
    Slavin, Thomas
    Cummings, Shelly
    Tedesco, Karen
    Reid, Robert
    GENETICS IN MEDICINE, 2022, 24 (03) : S34 - S34
  • [2] Managing Patient with Mutations in PALB2, CHEK2, or ATM
    Acevedo F.
    Deng Z.
    Armengol V.D.
    Hughes K.
    Current Breast Cancer Reports, 2018, 10 (2) : 74 - 82
  • [3] Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations
    Colin Bergstrom
    Colton Pence
    Jordan Berg
    Natalia Partain
    Navid Sadeghi
    Caitlin Mauer
    Sara Pirzadeh-Miller
    Ang Gao
    Hsiao Li
    Nisha Unni
    Samira Syed
    Annals of Surgical Oncology, 2021, 28 : 3383 - 3393
  • [4] Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations
    Bergstrom, Colin
    Pence, Colton
    Berg, Jordan
    Partain, Natalia
    Sadeghi, Navid
    Mauer, Caitlin
    Pirzadeh-Miller, Sara
    Gao, Ang
    Li, Hsiao
    Unni, Nisha
    Syed, Samira
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3383 - 3393
  • [5] Frequency of large rearrangements in BRCA1, BRCA2, ATM, CHEK2, and PALB2 in hereditary cancer testing
    Bissonnette, J.
    Doonanco, K.
    Xu, Z.
    Klein, R. T.
    Hruska, K. S.
    CANCER RESEARCH, 2016, 76
  • [6] Molecular analysis of breast cancers from individuals with hereditary cancer syndromes secondary to mutations in BRCA1, BRCA2, ATM, CHEK2, and PALB2
    Blum, Joanne L.
    Wong, Shukmei
    Pearson, Edward J.
    Nair, Anju
    Snipes, George J.
    Briones, Natalia
    Baker, Angela
    Cropp, Cheryl D.
    Carpten, John D.
    CANCER RESEARCH, 2018, 78 (04)
  • [7] Diagnosis, management, and surveillance for patients with PALB2, CHEK2, and ATM gene mutations
    Krupa, Kelly
    Kowzun, Maria
    Potdevin, Lindsay
    Kumar, Shicha
    Eladoumikdachi, Firas
    Fencer, Maria
    Bleich, Gabrielle
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 143 - 143
  • [8] Diagnosis, Management, and Surveillance for Patients With PALB2, CHEK2, and ATM Gene Mutations
    Fencer, Maria G.
    Krupa, Kelly A.
    Bleich, Gabrielle C.
    Grumet, Sherry
    Eladoumikdachi, Firas G.
    Kumar, Shicha
    Kowzun, Maria J.
    Potdevin, Lindsay B.
    CLINICAL BREAST CANCER, 2023, 23 (04) : E194 - E199
  • [9] Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
    Yadav, Siddhartha
    Boddicker, Nicholas J.
    Na, Jie
    Polley, Eric C.
    Hu, Chunling
    Hart, Steven N.
    Gnanaolivu, Rohan D.
    Larson, Nicole
    Holtegaard, Susan
    Huang, Huaizhi
    Dunn, Carolyn A.
    Teras, Lauren R.
    Patel, Alpa V.
    Lacey, James V.
    Neuhausen, Susan L.
    Martinez, Elena
    Haiman, Christopher
    Chen, Fei
    Ruddy, Kathryn J.
    Olson, Janet E.
    John, Esther M.
    Kurian, Allison W.
    Sandler, Dale P.
    O'Brien, Katie M.
    Taylor, Jack A.
    Weinberg, Clarice R.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Zirpoli, Gary
    Goldgar, David E.
    Palmer, Julie R.
    Domchek, Susan M.
    Weitzel, Jeffrey N.
    Nathanson, Katherine L.
    Kraft, Peter
    Couch, Fergus J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (09) : 1703 - +
  • [10] Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer
    Petridis, Christos
    Arora, Iteeka
    Shah, Vandna
    Moss, Charlotte L.
    Mera, Anca
    Clifford, Angela
    Gillett, Cheryl
    Pinder, Sarah E.
    Tomlinson, Ian
    Roylance, Rebecca
    Simpson, Michael A.
    Sawyer, Elinor J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (07) : 1162 - 1168
12345